Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125396161 | 12539616 | 1 | I | 2012 | 20160623 | 20160708 | 20160708 | EXP | DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119845 | RANBAXY | 50.00 | YR | F | Y | 96.00000 | KG | 20160708 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125396161 | 12539616 | 1 | SS | Norfloxacin | NORFLOXACIN | 1 | Oral | UNK | U | U | 0 | ||||||||
| 125396161 | 12539616 | 2 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | UNK | U | U | 75747 | ||||||||
| 125396161 | 12539616 | 3 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | UNK | U | U | 75747 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125396161 | 12539616 | 1 | Cystitis |
| 125396161 | 12539616 | 2 | Cystitis |
| 125396161 | 12539616 | 3 | Cystitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125396161 | 12539616 | OT |
| 125396161 | 12539616 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125396161 | 12539616 | Abdominal pain upper | |
| 125396161 | 12539616 | Anxiety | |
| 125396161 | 12539616 | Arthralgia | |
| 125396161 | 12539616 | Blood pressure increased | |
| 125396161 | 12539616 | Disturbance in attention | |
| 125396161 | 12539616 | Dizziness | |
| 125396161 | 12539616 | Dyspnoea | |
| 125396161 | 12539616 | Facial paralysis | |
| 125396161 | 12539616 | Fatigue | |
| 125396161 | 12539616 | Hypoaesthesia | |
| 125396161 | 12539616 | Muscular weakness | |
| 125396161 | 12539616 | Nausea | |
| 125396161 | 12539616 | Panic attack | |
| 125396161 | 12539616 | Presyncope | |
| 125396161 | 12539616 | Tinnitus | |
| 125396161 | 12539616 | Tremor | |
| 125396161 | 12539616 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125396161 | 12539616 | 1 | 20120710 | 0 | ||
| 125396161 | 12539616 | 2 | 20140622 | 0 | ||
| 125396161 | 12539616 | 3 | 20160617 | 0 |